New Research Coverage Highlights AVEO Pharmaceuticals, GMS, R1 RCM, Installed Building Products, Stoneridge, and Chicago Rivet & Machine — Consolidated Revenues, Company Growth, and Expectations for 2018

Loading...
Loading...

NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of AVEO Pharmaceuticals, Inc. AVEO, GMS Inc. GMS, R1 RCM Inc. RCM, Installed Building Products, Inc. IBP, Stoneridge, Inc. SRI, and Chicago Rivet & Machine Co. CVR, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

AVEO DOWNLOAD: http://Fundamental-Markets.com/register/?so=AVEO
GMS DOWNLOAD: http://Fundamental-Markets.com/register/?so=GMS
RCM DOWNLOAD: http://Fundamental-Markets.com/register/?so=RCM
IBP DOWNLOAD: http://Fundamental-Markets.com/register/?so=IBP
SRI DOWNLOAD: http://Fundamental-Markets.com/register/?so=SRI
CVR DOWNLOAD: http://Fundamental-Markets.com/register/?so=CVR

Loading...
Loading...

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine AVEO Pharmaceuticals, Inc. AVEO, GMS Inc. GMS, R1 RCM Inc. RCM, Installed Building Products, Inc. IBP, Stoneridge, Inc. SRI, and Chicago Rivet & Machine Co. CVR on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 26th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

AVEO PHARMACEUTICALS, INC. (AVEO) REPORT OVERVIEW

AVEO Pharmaceuticals' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, AVEO Pharmaceuticals reported revenue of $2.47MM vs $4.61MM (down 46.53%) and analysts estimated basic earnings per share -$0.18 vs -$0.22. For the twelve months ended December 31st, 2017 vs December 31st, 2016, AVEO Pharmaceuticals reported revenue of $7.58MM vs $2.52MM (up 201.35%) and analysts estimated basic earnings per share -$0.61 vs -$0.39. Analysts expect earnings to be released on March 12th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was -$0.08. The estimated EPS forecast for the next fiscal year is -$0.28 and is expected to report on March 12th, 2019.

To read the full AVEO Pharmaceuticals, Inc. (AVEO) report, download it here: http://Fundamental-Markets.com/register/?so=AVEO

-----------------------------------------

GMS INC. (GMS) REPORT OVERVIEW

GMS's Recent Financial Performance

For the three months ended July 31st, 2018 vs July 31st, 2017, GMS reported revenue of $778.14MM vs $642.16MM (up 21.18%) and analysts estimated basic earnings per share $0.21 vs $0.37 (down 43.24%). For the twelve months ended April 30th, 2018 vs April 30th, 2017, GMS reported revenue of $2,511.47MM vs $2,319.15MM (up 8.29%) and analysts estimated basic earnings per share $1.54 vs $1.21 (up 27.27%). Analysts expect earnings to be released on December 4th, 2018. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was $0.51. The estimated EPS forecast for the next fiscal year is $3.78 and is expected to report on June 27th, 2019.

To read the full GMS Inc. (GMS) report, download it here: http://Fundamental-Markets.com/register/?so=GMS

-----------------------------------------

R1 RCM INC. (RCM) REPORT OVERVIEW

R1 RCM's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, R1 RCM reported revenue of $250.40MM vs $123.20MM (up 103.25%) and analysts estimated basic earnings per share -$0.17 vs -$0.08. For the twelve months ended December 31st, 2017 vs December 31st, 2016, R1 RCM reported revenue of $449.80MM vs $592.60MM (down 24.10%) and analysts estimated basic earnings per share -$0.75 vs $0.65. Analysts expect earnings to be released on March 8th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was -$0.08. The estimated EPS forecast for the next fiscal year is -$0.03 and is expected to report on March 8th, 2019.

To read the full R1 RCM Inc. (RCM) report, download it here: http://Fundamental-Markets.com/register/?so=RCM

-----------------------------------------

INSTALLED BUILDING PRODUCTS, INC. (IBP) REPORT OVERVIEW

Installed Building Products' Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Installed Building Products reported revenue of $349.00MM vs $295.19MM (up 18.23%) and basic earnings per share $0.50 vs $0.38 (up 31.58%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Installed Building Products reported revenue of $1,132.93MM vs $862.98MM (up 31.28%) and analysts estimated basic earnings per share $1.30 vs $1.23 (up 5.69%). Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.23. The estimated EPS forecast for the next fiscal year is $2.97 and is expected to report on February 27th, 2019.

To read the full Installed Building Products, Inc. (IBP) report, download it here: http://Fundamental-Markets.com/register/?so=IBP

-----------------------------------------

STONERIDGE, INC. (SRI) REPORT OVERVIEW

Stoneridge's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Stoneridge reported revenue of $208.85MM vs $203.58MM (up 2.59%) and analysts estimated basic earnings per share $0.47 vs $0.29 (up 62.07%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Stoneridge reported revenue of $824.44MM vs $695.98MM (up 18.46%) and analysts estimated basic earnings per share $1.61 vs $2.79 (down 42.29%). Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.42. The estimated EPS forecast for the next fiscal year is $2.13 and is expected to report on February 27th, 2019.

To read the full Stoneridge, Inc. (SRI) report, download it here: http://Fundamental-Markets.com/register/?so=SRI

-----------------------------------------

CHICAGO RIVET & MACHINE CO. (CVR) REPORT OVERVIEW

Chicago Rivet & Machine's Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Chicago Rivet & Machine reported revenue of $8.86MM vs $8.39MM (up 5.59%) and analysts estimated basic earnings per share $0.30 vs $0.35 (down 14.29%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Chicago Rivet & Machine reported revenue of $35.76MM vs $37.02MM (down 3.40%) and analysts estimated basic earnings per share $2.15 vs $2.44 (down 11.89%). Analysts expect earnings to be released on March 19th, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full Chicago Rivet & Machine Co. (CVR) report, download it here: http://Fundamental-Markets.com/register/?so=CVR

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...